Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score ≥10.

Zev A WainbergCharles S FuchsJosep TaberneroKohei ShitaraKei MuroEric Van CutsemYung-Jue BangHyun Cheol ChungKensei YamaguchiEniko VargaJen-Shi ChenDaniel HochhauserPeter Thuss-PatienceSalah-Eddin Al-BatranMarcelo GarridoUma KherChie-Schin ShihSukrut ShahPooja BhagiaJoseph Chao

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)

This comprehensive analysis showed consistent improvements toward more favorable clinical outcomes with pembrolizumab across lines of therapy in patients with CPS ≥ 10 G/GEJ cancer.

Keyphrases

papillary thyroid
squamous cell
clinical trial
squamous cell carcinoma
randomized controlled trial
mesenchymal stem cells
smoking cessation